Table 3.

Receiver operating characteristic and reclassification analyses for MHR to discriminate the risk stratification of hyperuricemia

Model	AUC (95% CI)	P value	P for comparison	NRI (category free)	P value	IDI	P value
MHR	0.598 (0.587, 0.608)	< 0.001	–	–	–	–	–
Clinical risk factors*	0.718 (0.709, 0.728)	< 0.001	Reference	Reference	Reference	Reference	Reference
Clinical risk factors + MHR	0.724 (0.715, 0.734)	< 0.001	0.008	0.160 (0.096, 0.224)	< 0.001	0.003 (0.002, 0.005)	< 0.001

* Clinical risk factors: age, sex, current smoking, current drinking, BMI, eGFR, TC, HDL-C, SBP, FPG, history of CVD

Abbreviations: MHR Monocyte to high-density lipoprotein ratio, AUC area under the curve, CI confidence interval, NRI net reclassification improvement, IDI integrated discrimination improvement, BMI body mass index, eGFR estimated glomerular filtration rate, TC total cholesterol, HDL-C high density lipoprotein cholesterol, SBP systolic blood pressure, FPG fasting plasma glucose, CVD cardiovascular disease